Use of Antiviral Drugs to Reduce Household Transmission of Pandemic (H1N1) 2009, United Kingdom
Emerging Infectious Diseases, 2011 The United Kingdom implemented a containment strategy for pandemic (H1N1) 2009 through administering antiviral agents (AVs) to patients and their close contacts.
Richard G. Pebody +23 more
doaj +1 more source
The Effect of Risk Perception on the 2009 H1N1 Pandemic Influenza Dynamics [PDF]
, 2011 Background: The 2009 H1N1 pandemic influenza dynamics in Italy was characterized by a notable pattern: as it emerged from the analysis of influenza-like illness data, after an initial period (September–mid-October 2009) characterized by a slow ...
Poletti Piero +10 more
core +1 more source
Surveillance Lessons from First-wave Pandemic (H1N1) 2009, Northern California, USA
Emerging Infectious Diseases, 2010 After the appearance of pandemic (H1N1) 2009 in April 2009, influenza activity was monitored within the Kaiser Permanente Northern California division by using laboratory, pharmacy, telephone calls, and utilization (services patients received) data.
Roger Baxter
doaj +1 more source
Responses to Pandemic (H1N1) 2009, Australia
Emerging Infectious Diseases, 2010 In 2007, adults in Australia were interviewed about their willingness to comply with potential health interventions during a hypothetical influenza outbreak. After the first wave of pandemic (H1N1) 2009 in Australia, many of the same respondents were interviewed about behavior and protection measures they actually adopted.
Eastwood, Keith +3 more
openaire +4 more sources
Public preferences for vaccination and antiviral medicines under different pandemic flu outbreak scenarios. [PDF]
, 2015 During the 2009-2010 A(H1N1) pandemic, many people did not seek care quickly enough, failed to take a full course of antivirals despite being authorised to receive them, and were not vaccinated.
Yardley, Lucy +11 more
core +1 more source
Effectiveness of Seasonal Influenza Vaccine against Pandemic (H1N1) 2009 Virus, Australia, 2010
Emerging Infectious Diseases, 2011 To estimate effectiveness of seasonal trivalent and monovalent influenza vaccines against pandemic influenza A (H1N1) 2009 virus, we conducted a test-negative case–control study in Victoria, Australia, in 2010. Patients seen for influenza-like illness by
James E. Fielding +3 more
doaj +1 more source
Characterization of an artificial swine-origin influenza virus with the same gene combination as H1N1/2009 virus: a genesis clue of pandemic strain. [PDF]
PLoS ONE, 2011 Pandemic H1N1/2009 influenza virus, derived from a reassortment of avian, human, and swine influenza viruses, possesses a unique gene segment combination that had not been detected previously in animal and human populations.
Xueli Zhao +11 more
doaj +1 more source
Pandemic (H1N1) 2009 in Skunks, Canada
Emerging Infectious Diseases, 2010 To the Editor: In March 2009, a novel influenza virus A (H1N1) emerged in Mexico, and, because of widespread human-to-human transmission, a global pandemic was declared in June 2009 (1). Although most cases have involved humans, pandemic (H1N1) 2009 has sporadically infected swine and turkeys and has also been reported in a small number of pet ferrets,
Ann P. Britton +3 more
openaire +3 more sources
Antibody response of healthy children to pandemic A/H1N1/2009 influenza virus
Virology Journal, 2011 Background Little is known about the proportion of pediatric pandemic A/H1N1/2009 influenza cases who showed seroconversion, the magnitude of this seroconversion, or the factors that can affect the antibody level evoked by the pandemic A/H1N1/2009 ...
Esposito Susanna +8 more
doaj +1 more source
Socioeconomic burden of influenza in the Republic of Korea, 2007-2010. [PDF]
PLoS ONE, 2013 BACKGROUND: Although the socioeconomic burden of 2009 pandemic influenza A (H1N1) was considerable, no reliable estimates have been reported. Our aim was to compared medical costs and socioeconomic burden resulting from pandemic influenza A (H1N1) 2009 ...
Mina Suh +14 more
doaj +1 more source